Cell Source, Inc.
- Close
- Sep 17, 2026 · -24.14%
- Market cap
- $29.90M
- 67.95M shares
- Filings
- 139
—
—
—Q1 2025N/M FY24 yoy
Q1 2025N/M FY24 yoy
FY 2014derivedN/M FY14 yoy
Q1 2025N/M FY24 yoy
Q1 2025+236.1% FY24 yoy
- $29.90M
- —
- —
- —
- —
- —
Price
Sep 17, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | $1,938,173 | reported | |
| FY 2021 | 2021-12-31 | $1,273,352 | reported | |
| FY 2020 | 2020-12-31 | $834,943 | reported | |
| FY 2019 | 2019-12-31 | $2,457,051 | reported | |
| FY 2018 | 2018-12-31 | $274,937 | reported | |
| FY 2017 | 2017-12-31 | $637,318 | reported | |
| FY 2016 | 2016-12-31 | $554,185 | reported | |
| FY 2015 | 2015-12-31 | $392,925 | reported | |
| FY 2014 | 2014-12-31 | $806,157 | reported | |
| FY 2013 | 2013-12-31 | $351,513 | reported |
Pharmaceutical preparations
Cell Source, Inc. is the 364th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
PMNProMIS Neurosciences Inc.———$31.6MBCTXBriaCell Therapeutics Corp.———$30.4M
CLCSCell Source, Inc. (this company)———$29.9M
RMTIRockwell Medical, Inc.$69.3M31.8%7.7%$29.6MPVCTProvectus Biopharmaceuticals, Inc.$336.1K45.5%1,615.8%$29.2MBETRFBetterLife Pharma Inc.Fiscal 2018 figures———$28.9MNXTCNextCure, Inc.———$28.0MACETAdicet Bio, Inc.———$27.6MCRVOCervoMed Inc.$4.0M58.9%673.1%$27.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Cell Source, Inc. · CIK 1569340 · Engraved from SEC EDGAR